BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 10 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,603,000 | +68.6% | 322,413 | -1.8% | 6.64% | +87.0% |
| Q2 2020 | $7,473,000 | +171.6% | 328,475 | -8.1% | 3.55% | +28.0% |
| Q1 2020 | $2,751,000 | -72.5% | 357,240 | -66.8% | 2.77% | +4371.0% |
| Q4 2019 | $10,005,000 | +368.0% | 1,077,000 | +200.0% | 0.06% | -54.1% |
| Q3 2019 | $2,138,000 | +3.4% | 359,000 | 0.0% | 0.14% | -20.1% |
| Q2 2019 | $2,068,000 | +6.1% | 359,000 | 0.0% | 0.17% | -2.9% |
| Q1 2019 | $1,949,000 | +13.8% | 359,000 | 0.0% | 0.17% | -37.6% |
| Q4 2018 | $1,712,000 | -14.8% | 359,000 | 0.0% | 0.28% | -75.0% |
| Q3 2018 | $2,010,000 | -16.1% | 359,000 | 0.0% | 1.12% | -17.8% |
| Q2 2018 | $2,395,000 | +22.8% | 359,000 | 0.0% | 1.36% | -15.4% |
| Q1 2018 | $1,950,000 | +1.4% | 359,000 | 0.0% | 1.61% | +43.8% |
| Q4 2017 | $1,924,000 | – | 359,000 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRUE Private Wealth Advisors | 55,500 | $64,000 | 0.01% |
| Aspire Private Capital, LLC | 1,600 | $2,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,540 | $3,000 | 0.00% |
| UBS Group AG | 4,692 | $5,000 | 0.00% |
| CREDIT AGRICOLE S A | 4,240 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,768 | $16,000 | 0.00% |
| MORGAN STANLEY | 33,281 | $39,000 | 0.00% |
| Renaissance Technologies | 18,300 | $21,000 | 0.00% |